Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Development of an Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) Method for Measurement of Urine Iodine & Assessment of Iodine Status in Subclinical Hypothyroidism K Jones1, J Rogers1, A DeLloyd2, DA Rees3, M Ludgate2, C Evans1 1Medical Biochemistry & Immunology, University Hospital of Wales, Cardiff, UK. Email: [email protected] Research Group, Institute for Molecular & Experimental Medicine, School of Medicine, Cardiff University, UK 3Cardiovascular & Metabolism Research Group, Institute for Molecular & Experimental Medicine, Cardiff University, UK 2Thyroid Introduction A B Linearity 127I ISTD:125Te y=0.0049x+0.0085 • Standard curves were linear with a correlation coefficient consistently >0.999 (figure 2) • Dilution of urine iodine was linear over the range 1–2527 µg/L R=1.0000 Ratio • Iodine (I) is a component of thyroid hormones thyroxine (T4) and triiodothyronine (figure 1) Method Validation 500 1000 Iodine concentration (ppb) Figure 2: Representative standard curve Figure 1: Structure of (A) thyroxine, (B) triiodothyronine • Iodine deficiency may lead to reduced thyroid hormone production & consequences including goitre, hypothyroidism, foetal abnormalities, mental retardation & susceptibility to iodine-induced hyperthyroidism1 • A recent study suggests the UK may be iodine deficient2, indicating the need for further research • Population iodine status can be assessed by measurement of urine iodine1, for which ICP-MS is the gold standard method3 Aims 1. To develop & validate a method for measurement of urine iodine by ICP-MS 2. To apply this method to a local population with subclinical hypothyroidism Methods ICP-MS Analysis was carried out on an Agilent 7700x ICPMS with autosampler and integrated sample introduction system. Helium gas (5mL/min) was used in the collision cell and iodine was monitored at m/z 127. Aqueous iodine standards 0-1000µg/L (0-7800nmol/L) (Inorganic Ventures) were used for calibration. Standards, samples and quality control material were diluted 1 in 20 in diluent (1% TMAH, 100ppb 125Te (Inorganic Ventures), 0.01% Triton-X). Quality control material consisted of Seronorm Urine Level 2 (Alere Ltd) and urine pools (3 levels) prepared in house. The laboratory enrolled in the CDC EQUIP (Ensuring the Quality of Urinary Iodine Procedures) EQA scheme. Accuracy Sensitivity • LLOD 2 µg/L (17 nmol/L) • LLOQ 1 µg/L (8 nmol/L) Recovery Iodine concentration (µg/L) % recovery 200 400 600 800 1000 120 107 107 104 103 Figure 3: Difference plot showed no method bias compared to CDC target values in sixteen EQA samples Table 2: Recovery of iodine in urine Precision Carryover Urine iodine concentration (µg/L) 21 Intra-assay CV (%) Inter-assay 3.6 3.0 286 788 2.2 1.7 2.1 1.1 No carryover was observed during analysis of blank samples following the top standard (1000 µg/L) or urine samples (>2500 µg/L) Table 1: Intra- and inter-assay CV Iodine status in subclinical hypothyroidism • The population median urine iodine concentration was 94 µg/L (0.73 µmol/L), consistent with mild iodine deficiency1 • A wide range of iodine excretion was observed: 8–3341 µg/L (0.06–26.33 µmol/L) • No correlation was observed between urine iodine and TSH (figure 4) or free T4 Figure 4: Scatter plot showing relationship between urine iodine and TSH (n=203) Subclinical hypothyroidism study Spot urines were collected from 203 individuals (20-71 years (median 54.5 years), 75% female, 90% Caucasian) enrolled in a local study on subclinical hypothyroidism (selection criteria TSH 5-10mU/L, fT4 within reference range). Ethical approval was granted for this study. Participants had repeat thyroid function (TSH & fT4) at the time of urine collection. References Mild deficiency Moderate deficiency Severe deficiency Summary 1World Health Organization (2007). Assessment of iodine deficiency disorders and monitoring their elimination. www.who.int/nutrition/publications/en/ 2Vanderpump, Lazarus, Smyth et al. (2011). Lancet. 377:2007-12 3Jooste & Strydom (2010). Best Pract Res Clin Endocrinol Metab. 24:77-88 Acknowledgements: Steven Smith (University Hospital of Wales, UK) • An ICP-MS method for urine iodine has been successfully developed and validated • Application of this method revealed mild iodine deficiency in a local study population • Urine iodine does not correlate with TSH or fT4 in this population